Syngene International is all set to make an additional investment of upto $56 million in equity share capital of Syngene USA Inc (SUSA), a wholly owned subsidiary of the Company, in one or more tranches. The investment will be utilised to finance the cost of acquisition of biologics facility from Emergent Manufacturing Operations Baltimore, LLC., and for meeting the general corporate, and day-to-day operating requirements.
The investment is expected to be completed on or before March 31, 2026 or such other date mutually agreed between the parties. There will be no change in shareholding of the Company in SUSA. SUSA will continue to remain a wholly owned subsidiary of the Company.
Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 443.50 |
| Indegene | 487.75 |
| CMS Info Systems | 312.95 |
| JITF Infralogistics | 324.65 |
| Sagility | 42.24 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: